CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Class A and B common stock	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income (loss)	Retained earnings (Accumulated deficit)	Retained earnings (Accumulated deficit) Cumulative Effect, Period of Adoption, Adjustment	Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2020			456,184,776
Beginning balance at Dec. 31, 2020	$ 2,681,569	$ (399,734)	$ 0	$ 2,955,464	$ (502,708)	$ 23,328	$ (297,223)	$ 102,974	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	39,008						39,008
Shares issued in connection with employee stock plans (in shares)			4,311,094
Shares issued in connection with employee stock plans	32,891			32,891
Change in other comprehensive income (loss)	(13,129)					(13,129)
Share-based compensation	121,965			121,965
Tax withholding related to vesting of restricted stock units (in shares)			(669,076)
Tax withholding related to vesting of restricted stock units	(152,013)			(152,013)
Issuance of common stock in connection with business combination (in shares)			166,967
Issuance of common stock in connection with business combination	3,816			3,816
Exercise of bond hedges in conjunction with the conversion of convertible notes (in shares)			(5,325,320)
Ending balance (in shares) at Mar. 31, 2021			454,668,441
Ending balance at Mar. 31, 2021	2,314,373		$ 0	2,459,415		10,199	(155,241)		0
Beginning balance (in shares) at Dec. 31, 2021			464,943,787
Beginning balance at Dec. 31, 2021	3,313,589		$ 0	3,317,255		(16,435)	(27,965)		40,734
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(207,363)						(204,199)		(3,164)
Shares issued in connection with employee stock plans (in shares)			2,119,899
Shares issued in connection with employee stock plans	4,093			4,093
Change in other comprehensive income (loss)	234,792					234,792
Share-based compensation	279,354			279,354
Tax withholding related to vesting of restricted stock units (in shares)			(16,003)
Tax withholding related to vesting of restricted stock units	(2,456)			(2,456)
Issuance of common stock in connection with business combination (in shares)			113,617,352
Issuance of common stock in connection with business combination	13,827,929			13,827,929
Issuance of common stock in conjunction with the conversion of convertible notes (in shares)			19,865
Issuance of common stock in conjunction with the conversion of convertible notes	454			454
Exercise of bond hedges in conjunction with the conversion of convertible notes (in shares)			(1,188,754)
Ending balance (in shares) at Mar. 31, 2022			579,496,146
Ending balance at Mar. 31, 2022	$ 17,450,392		$ 0	$ 17,426,629		$ 218,357	$ (232,164)		$ 37,570